Sponsored by sanofi aventis, this conference focused on the new health care reform law and its provisions for approval and substitutability of follow-on biologics (also known as biosimilars).

On December 15, 2011, the Center on Drugs and Public Policy (CDPP) at the University of Maryland School of Pharmacy hosted an invitational conference entitled "Critical Issues Related to Regulation of Follow-on Biologics." This conference was held at the Washington Marriott at Metro Center in Washington, DC. For more information about this conference, including the conference program, presentations, and related guidances, please explore the links below.